MUC1 and cancer: Apart from that, cancer growth was inhibited within immunodeficient mice bearing BDC xenografts, and a new PD-1 inhibitor conjugated to anti-CD3 and anti-MUC1 bsAbs was analyzed in a Phase II RCT (NCT03524261) in advanced BRCA cases, but no further information is available [83].